247 related articles for article (PubMed ID: 9930766)
1. The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS.
Chen G; Zeng WZ; Yuan PX; Huang LD; Jiang YM; Zhao ZH; Manji HK
J Neurochem; 1999 Feb; 72(2):879-82. PubMed ID: 9930766
[TBL] [Abstract][Full Text] [Related]
2. Common effects of lithium and valproate on mitochondrial functions: protection against methamphetamine-induced mitochondrial damage.
Bachmann RF; Wang Y; Yuan P; Zhou R; Li X; Alesci S; Du J; Manji HK
Int J Neuropsychopharmacol; 2009 Jul; 12(6):805-22. PubMed ID: 19149911
[TBL] [Abstract][Full Text] [Related]
3. Differential display PCR reveals novel targets for the mood-stabilizing drug valproate including the molecular chaperone GRP78.
Wang JF; Bown C; Young LT
Mol Pharmacol; 1999 Mar; 55(3):521-7. PubMed ID: 10051536
[TBL] [Abstract][Full Text] [Related]
4. Mood stabilizers commonly restore staurosporine-induced increase of p53 expression and following decrease of Bcl-2 expression in SH-SY5Y cells.
Song N; Boku S; Nakagawa S; Kato A; Toda H; Takamura N; Omiya Y; Kitaichi Y; Inoue T; Koyama T
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):183-9. PubMed ID: 22484386
[TBL] [Abstract][Full Text] [Related]
5. Cell-type specific regulation of calreticulin and Bcl-2 expression by mood stabilizer drugs.
Corson TW; Woo KK; Li PP; Warsh JJ
Eur Neuropsychopharmacol; 2004 Mar; 14(2):143-50. PubMed ID: 15013030
[TBL] [Abstract][Full Text] [Related]
6. Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications.
Manji HK; Bebchuk JM; Moore GJ; Glitz D; Hasanat KA; Chen G
J Clin Psychiatry; 1999; 60 Suppl 2():27-39; discussion 40-1, 113-6. PubMed ID: 10073385
[TBL] [Abstract][Full Text] [Related]
7. Neuroactive steroids, mood stabilizers, and neuroplasticity: alterations following lithium and changes in Bcl-2 knockout mice.
Marx CE; Yuan P; Kilts JD; Madison RD; Shampine LJ; Manji HK
Int J Neuropsychopharmacol; 2008 Jun; 11(4):547-52. PubMed ID: 18257969
[TBL] [Abstract][Full Text] [Related]
8. Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: implications for the pathophysiology and treatment of manic-depressive illness.
Manji HK; Moore GJ; Chen G
Biol Psychiatry; 2000 Oct; 48(8):740-54. PubMed ID: 11063971
[TBL] [Abstract][Full Text] [Related]
9. The antiapoptotic actions of mood stabilizers: molecular mechanisms and therapeutic potentials.
Chuang DM
Ann N Y Acad Sci; 2005 Aug; 1053():195-204. PubMed ID: 16179524
[TBL] [Abstract][Full Text] [Related]
10. Role of glutathione in neuroprotective effects of mood stabilizing drugs lithium and valproate.
Cui J; Shao L; Young LT; Wang JF
Neuroscience; 2007 Feb; 144(4):1447-53. PubMed ID: 17184924
[TBL] [Abstract][Full Text] [Related]
11. Lithium at 50: have the neuroprotective effects of this unique cation been overlooked?
Manji HK; Moore GJ; Chen G
Biol Psychiatry; 1999 Oct; 46(7):929-40. PubMed ID: 10509176
[TBL] [Abstract][Full Text] [Related]
12. The anti-apoptotic, glucocorticoid receptor cochaperone protein BAG-1 is a long-term target for the actions of mood stabilizers.
Zhou R; Gray NA; Yuan P; Li X; Chen J; Chen G; Damschroder-Williams P; Du J; Zhang L; Manji HK
J Neurosci; 2005 May; 25(18):4493-502. PubMed ID: 15872096
[TBL] [Abstract][Full Text] [Related]
13. FGF-21, a novel metabolic regulator, has a robust neuroprotective role and is markedly elevated in neurons by mood stabilizers.
Leng Y; Wang Z; Tsai LK; Leeds P; Fessler EB; Wang J; Chuang DM
Mol Psychiatry; 2015 Feb; 20(2):215-23. PubMed ID: 24468826
[TBL] [Abstract][Full Text] [Related]
14. The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons.
Yasuda S; Liang MH; Marinova Z; Yahyavi A; Chuang DM
Mol Psychiatry; 2009 Jan; 14(1):51-9. PubMed ID: 17925795
[TBL] [Abstract][Full Text] [Related]
15. Glutathione S-transferase is a novel target for mood stabilizing drugs in primary cultured neurons.
Wang JF; Shao L; Sun X; Young LT
J Neurochem; 2004 Mar; 88(6):1477-84. PubMed ID: 15009649
[TBL] [Abstract][Full Text] [Related]
16. Chronic treatment with mood stabilizers lithium and valproate prevents excitotoxicity by inhibiting oxidative stress in rat cerebral cortical cells.
Shao L; Young LT; Wang JF
Biol Psychiatry; 2005 Dec; 58(11):879-84. PubMed ID: 16005436
[TBL] [Abstract][Full Text] [Related]
17. Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness.
Manji HK; Moore GJ; Chen G
J Clin Psychiatry; 2000; 61 Suppl 9():82-96. PubMed ID: 10826666
[TBL] [Abstract][Full Text] [Related]
18. Chronic treatment with lithium or valproate modulates the expression of Homer1b/c and its related genes Shank and Inositol 1,4,5-trisphosphate receptor.
de Bartolomeis A; Tomasetti C; Cicale M; Yuan PX; Manji HK
Eur Neuropsychopharmacol; 2012 Jul; 22(7):527-35. PubMed ID: 22245542
[TBL] [Abstract][Full Text] [Related]
19. Effects of mood-stabilizing drugs on dendritic outgrowth and synaptic protein levels in primary hippocampal neurons.
Park SW; Lee JG; Seo MK; Cho HY; Lee CH; Lee JH; Lee BJ; Baek JH; Seol W; Kim YH
Bipolar Disord; 2015 May; 17(3):278-90. PubMed ID: 25307211
[TBL] [Abstract][Full Text] [Related]
20. Identification of mood stabilizer-regulated genes by differential-display PCR.
Wang JF; Bown CD; Chen B; Young LT
Int J Neuropsychopharmacol; 2001 Mar; 4(1):65-74. PubMed ID: 11343631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
